Immune-modulating enteral formulations: Optimum components, appropriate patients, and controversial use of arginine in sepsis

Current Gastroenterology Reports

Volumn 9, Issue 4, 2007, Pages 329-337

  Zhou, Minhao ^b   Martindale, Robert G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALANYLGLUTAMINE; ANTIOXIDANT; ARGININE; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; GLUTAMINE; ICOSAPENTAENOIC ACID; MEDIUM CHAIN TRIACYLGLYCEROL; NITRIC OXIDE; NUCLEOTIDE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; PROLINE; SHORT CHAIN FATTY ACID;

ABSENCE OF SIDE EFFECTS; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; CYTOTOXICITY; DIETARY INTAKE; DRUG SAFETY; ELEMENTAL DIET; ENTERIC FEEDING; HUMAN; IMMUNOMODULATION; INFLAMMATION; LOW DRUG DOSE; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL REQUIREMENT; NUTRITIONAL SUPPORT; NUTRITIONAL VALUE; REVIEW; SEPSIS;

ANIMALS; ARGININE; ENTERAL NUTRITION; HUMANS; NUTRITIONAL STATUS; SEPSIS; TREATMENT OUTCOME;

EID: 34848893663     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-007-0038-8     Document Type: Review

References (65)

1. Proceedings from Summit on Immune-Enhancing Enteral Therapy. San Diego, CA; May 25-26, 2000. JPEN J Parenter Enteral Nutr 2001, 25:S1-S63.
2. Beale RJ, Bryg DJ, Bihari DJ: Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999, 27:2799-2805.
3. Heyland DK, Novak F, Drover JW, et al.: Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001, 286:944-953.
4. Heys SD, Walker LG, Smith 1, Eremin O: Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 1999, 229:467-477.
5. Montejo JC, Zarazaga A, Lopez-Martinez J, et al.: Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr 2003, 22:221-233.
6. Waitzberg DL, Saito H, Plank LD, et al.: Postsurgical infections are reduced with specialized nutrition support. World J Surg 2006, 30:1592-1604.
7. Mizock BA, DeMichele SJ: The acute respiratory distress syndrome: role of nutritional modulation of inflammation through dietary lipids. Nutr Clin Pract 2004, 19:563-S74.
8. Calder PC: Fatty acids and gene expression related to inflammation. Nestle Nutr Worksbop Ser Clin Perform Programme 2002, 7 :19-36.
9. Cornell TT, Shanley TP: Signal transduction overview. Crit Care Med 2005, 33:S410-S413.
10. Calder PC: Dietary modification of inflammation with lipids. Proc Nutr Soc 2002, 61:345-358.
11. Serhan CN: Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr Opin Clin Nutr Metab Care 2005, 8:115-121.
12. Bruckner G: Microcirculation, vitamin E and omega 3 fatty acids: an overview. Adv Exp Med Biol 1997, 415:195-208.
13. McGuinness J, Neilan TG, Sharkasi A, et al.: Myocardial protection using an omega-3 fatty acid infusion: quantification and mechanism of action. J Thorac Cardiovasc Surg 2006, 132:72-79.
14. Pacht ER, DeMichele Sj, Nelson JL, et al.: Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med 2003, 31:491-500.
15. Heller AR, Rossler S, Litz RJ, et al.: Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 2006, 34:972-979.
16. Braga M, Gianotti L, Nespoli L, et al.: Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg 2002, 137:174-180.
17. Heyland DK, Dhaliwal R, Day AG, et al.: REducing Deaths due to OXidative Stress (The REDOXS Study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc 2006, 65:250-263.
18. Heyland DK, Dhaliwal R, Suchner U, Berger MM: Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 2005, 31:327-337.
19. Nathens AB, Neff Mj, jurkovich GJ, et al.: Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002, 236:814-822.
20. Crimi E, Sica V, Williams-Ignarro S, et al.: The role of oxidative stress in adult critical care. Free Radic Biol Med 2006, 40:398-406.
21. Carver JD: Dietary nucleotides: cellular immune, intestinal and hepatic system effects. J Nutr 1994, 124:144S-148S.
22. Jyonouchi H: Nucleotide actions on Immoral immune responses. J Nutr 1994, 124:138S-143S.
23. Van Buren CT, Kulkarni AD, Rudolph FB: The role of nucleotides in adult nutrition. J Nutr 1994, 124:160S-164S.
24. Wischmeyer PE: Glutamine: role in gut protection in critical illness. Curr Opin Clin Nutr Metab Care 2006, 9:607-612.
25. Alpers DH: Glutamine: do the data support the cause for glutamine supplementation in humans? Gastroenterology 2006, 130:S106-116.
26. Ziegler TR, Bazargan N, Galloway JR: Glutamine supplemented nutrition support: saving nitrogen and saving money? Clin Nutr 2000, 19:375-377.
27. Griffiths RD: Glutamine: establishing clinical indications. Curr Opin Clin Nutr Metab Care 1999, 2:177-182.
28. Houdijk AP, Rijnsburger ER, Jansen J, et al.: Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998, 352:772-776.
29. Dechelotte P, Hasselmann M, Cynober L, et al.: L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 2006, 34:598-604.
30. Byrne TA, Wilmore DW, Iyer K, et al.: Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Ann Surg 2005, 242:655-661.
31. De Bandt A Cynober LA: Amino acids with anabolic properties. Curr Opin Clin Nutr Metab Care 1998, 1:263-272.
32. Dhaliwal R, Heyland DK: Nutrition and infection in the intensive care unit: what does the evidence show? Curr Opin Crit Care 2005, 11:461-467.
33. Kudsk KA: Immunonutrition in surgery and critical care. Annu Rev Nutr 2006, 26:463-479.
34. Singleton KD, Serkova N, Beckey VE, Wischmeyer PE: Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Crit Care Med 2005, 33:1206-1213.
35. Ziegler TR, Ogden LG, Singleton KD, et al.: Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med 2005, 31:1079-1086.
36. Stehle P, Zander J, Mertes N, et al.: Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet 1989, 1:231-233.
37. Griffiths RD: Outcome of critically ill patients after supplementation with glutamine. Nutrition 1997, 13:752-754.
38. Ziegler TR, Young LS, Benfell K, et al.: Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 1992, 116:821-828.
39. Anderson PM, Schroeder G, Skubitz KM: Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 1998, 83:1433-1439.
40. Yoshida S, Matsui M, Shirouzu Y, et al.: Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer. Ann Surg 1998, 227:485-491.
41. Morris SM Jr: Recent advances in arginine metabolism. Curr Opin Clin Nutr Metab Care 2004, 7:45-51.
42. Satriano J: Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article. Amino Acids 2004, 26:321-329.
43. Albina JE, Mills CD, Henry WL Jr, Caldwell MD: Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway. J Immunol 1989, 143:3641-3646.
44. Gianotti L, Alexander JW, Pyles T, Fukushima R: Arginine-supplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance. The role of nitric oxide. Ann Surg 1993, 217:644-653.
45. Marin VB, Rodriguez-Osiac L, Schlessinger L, et al.: Controlled study of enteral arginine supplementation in burned children: impact on immunologic and metabolic status. Nutrition 2006, 22:705-712.
46. Luiking YC, Poeze M, Dejong CH, et al.: Sepsis: an arginine deficiency state? Crit Care Med 2004, 32:2135-2145.
47. Bansal V, Ochoa JB: Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care 2003, 6:223-228.
48. Rodriguez PC, Zea AH, DeSalvo J, et al.: L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol 2003, 171:1232-1239.
49. Heys SD, Stott SA, Noble DW: Immune-enhancing diets. Crit Care Med 2000, 28:904-906.
50. Luiking Y, Deby-Dupont G, Poeze M, et al.: L-arginine infusion in severely septic patients does not enhance protein nitrosylation or haemodynamic instability. In. Abstract from ESPEN meeting Istanbul Turkey: Maastricht University Hospital; October 2006, 0006.
51. Galban C, Montejo JC, Mesejo A, et al.: An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 2000, 28:643-648.
52. Bertolini G, Iapichino G, Radrizzani D, et al.: Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 2003, 29:834-840.
53. Bower RH, Cerra FB, Bershadsky B, et al.: Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995, 23:436-449.
54. Caparros T, Lopez J, Grau T. Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet. The effect on nosocomial infections and outcome. JPEN J Parenter Enteral Nutr 2001, 25:299-308; discussion 308-299.
55. Dent DL, Heyland DK, Levy H, Martindale RG: Immunonutrition may increase mortality in critically ill patients with pneumonia: Results of a randomized trial. Crit Care Med 2003, 30:Abstract, A17.
56. Kieft H, Roos AN, van Drunen JD, et al.: Clinical outcome of immunonutrition in a heterogeneous intensive care population. Intensive Care Med 2005, 31:524-532.
57. Suchner U, Heyland DK, Peter K: Immune-modulatory actions of arginine in the critically ill. Br J Nutr 2002, 87(Suppl 1):S121-S132.
58. Cynober L: Immune-enhancing diets for stressed patients with a special emphasis on arginine content: analysis of the analysis. Curr Opin Clin Nutr Metab Care 2003, 6:189-193.
59. Alexander JW, Metze TJ, McIntosh MJ, et al.: The influence of immunomodulatory diets on transplant success and complications. Transplantation 2005, 79:460-465.
60. Bansal V, Syres KM, Makarenkova V, et al.: Interactions between fatty acids and arginine metabolism: implications for the design of immune-enhancing diets. JPEN J Parenter Enteral Nutr 2005, 29:S75-S80.
61. Gianotti L, Braga M, Nespoli L, et al.: A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002, 122:1763-1770.
62. Zaloga GP, Roberts PR, Marik P: Feeding the hemodynamically unstable patient: a critical evaluation of the evidence. Nutr Clin Pract 2003, 18:285-293.
63. Sato N, Moore FA, Smith MA, et al.: Immune-enhancing enteral nutrients differentially modulate the early proiaflammatory transcription factors mediating gut ischemia/reperfusion. J Trauma 2005, 58:455-461.
64. Chiarla C, Giovannini I, Siegel JH: Plasma arginine correlations in trauma and sepsis. Amino Acids 2006, 30:81-86.
65. Pan M, Choudry HA, Epler MJ, et al.: Arginine transport in catabolic disease states. J Nutr 2004, 134:2826S-2829S.